We are live on ! Find out more
PPH icon

VanEck Pharmaceutical ETF
PPH

138 hedge funds and large institutions have $417M invested in VanEck Pharmaceutical ETF in 2024 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 39 increasing their positions, 34 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

322% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 9

227% more call options, than puts

Call options by funds: $1.63M | Put options by funds: $499K

25% more funds holding

Funds holding: 110 → 138 (+28)

15% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 34

6% more capital invested

Capital invested by funds: $394M → $417M (+$23.4M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

11.47% less ownership

Funds ownership: 88.94% → 77.47% (-11%)

Holders
138
Holders Change
+28
Holders Change %
+25.45%
% of All Funds
1.99%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
38
Increased
39
Reduced
34
Closed
9
Calls
$1.63M
Puts
$499K
Net Calls
+$1.13M
Net Calls Change
+$4.11M

Top Buyers

Rank Fund Capital Flow
1
JSAM
J. Safra Asset Management
New York
+$6.09M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$3.58M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$3.27M
4
BHB
Bank Hapoalim BM
Israel
+$3.09M
5
Jane Street
Jane Street
New York
+$3.05M

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$19M
2
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$8.76M
3
VV
Verity & Verity
South Carolina
-$7.77M
4
Morgan Stanley
Morgan Stanley
New York
-$6.41M
5
VAS
Valicenti Advisory Services
New York
-$4.96M
Name Holding Trade Value Shares
Change 		Change in
Stake
GS
76
GTS Securities
New York
$394K – – –
Cohen & Steers
77
Cohen & Steers
New York
$385K – – –
NA
78
NewEdge Advisors
Louisiana
$379K +$366K +4,176 New
Vontobel Holding
79
Vontobel Holding
Switzerland
$363K – – –
SFG
80
Summit Financial Group
West Virginia
$348K +$336K +3,835 New
Barclays
81
Barclays
United Kingdom
$347K -$764K -8,724 -69%
ASFA
82
All Season Financial Advisors
Colorado
$334K +$322K +3,678 New
Neuberger Berman Group
83
Neuberger Berman Group
New York
$326K – – –
TRCT
84
Tower Research Capital (TRC)
New York
$325K -$1.68M -19,141 -84%
Bank of Montreal
85
Bank of Montreal
Ontario, Canada
$325K +$26.7K +305 +9%
EIP
86
Ellis Investment Partners
Pennsylvania
$314K +$303K +3,466 New
TC
87
TownSquare Capital
Utah
$312K +$301K +3,438 New
BCM
88
Barometer Capital Management
Ontario, Canada
$298K +$298K +3,400 New
MML Investors Services
89
MML Investors Services
Massachusetts
$294K +$283K +3,237 New
Wealth Enhancement Advisory Services
90
Wealth Enhancement Advisory Services
Minnesota
$286K +$13.2K +151 +5%
Northern Trust
91
Northern Trust
Illinois
$276K +$267K +3,048 New
GCM
92
Glaxis Capital Management
Florida
$272K +$263K +3,000 New
NFG
93
Nadler Financial Group
Illinois
$272K – – –
LSA
94
L & S Advisors
California
$268K +$259K +2,954 New
HI
95
Harbour Investments
Wisconsin
$266K +$112K +1,275 +77%
KIA
96
KCM Investment Advisors
California
$265K -$26.3K -300 -9%
Cambridge Investment Research Advisors
97
Cambridge Investment Research Advisors
Iowa
$258K +$249K +2,847 New
CIBC World Market
98
CIBC World Market
Ontario, Canada
$255K +$30.7K +351 +14%
AIP
99
Almanack Investment Partners
Pennsylvania
$251K – – –
EFA
100
Edge Financial Advisors
Illinois
$248K +$240K +2,739 New
2 3
4
5 6

PPH Hedge Fund Activity: Q1 2024 in Review

138 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in VanEck Pharmaceutical ETF (PPH) for Q1 2024, worth a combined $417M — up 5.9% from $394M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new PPH positions and 9 closed out — a net gain of 29 holders — while 39 added to existing stakes and 34 trimmed.

The largest buyer was J. Safra Asset Management, opening a new position worth an estimated $6.09M. The largest seller was Bank of America, cutting an estimated $19M.

  • 138 institutional investors held VanEck Pharmaceutical ETF (PPH) as of Q1 2024, up from 110 in Q4 2023.
  • Funds reported $417M of VanEck Pharmaceutical ETF stock for Q1 2024, up 5.9% quarter-over-quarter.
  • 38 funds opened new VanEck Pharmaceutical ETF positions in Q1 2024 and 9 closed out, a net change of +29 holders.
  • The largest VanEck Pharmaceutical ETF buyer in Q1 2024 was J. Safra Asset Management, an estimated $6.09M added.
  • The largest VanEck Pharmaceutical ETF seller in Q1 2024 was Bank of America, an estimated $19M sold.

Based on aggregated 13F filings for Q1 2024.